Home Monitoring for Interstitial Lung Disease

(RESPOND-ILD Trial)

This trial aims to identify the most effective home monitoring tools for tracking interstitial lung disease (ILD) events. Participants will use various combinations of devices, such as a spirometer (to measure lung function), a pulse oximeter (to check blood oxygen), and a scale, to determine which setup is easiest to use and provides the best data. The trial seeks individuals diagnosed with specific types of ILD, like idiopathic pulmonary fibrosis, who can regularly use these devices at home. This study is part of the Home Monitoring in Patients with f-ILD initiative. As an unphased trial, it offers a unique opportunity to contribute to research that could enhance daily life for ILD patients.

Studies have shown that home monitoring devices like spirometers (which measure lung function), pulse oximeters (which check oxygen levels), and scales (for weight) are generally safe. Spirometry is a common method for tracking lung health and is typically easy for patients to use. Pulse oximeters are widely used at home without major safety concerns. Scales provide a standard and safe way to measure weight.

The devices used in this study are non-invasive, meaning they do not enter the body and are unlikely to cause harm. Some individuals might find using these devices slightly uncomfortable at first, but they are not known to cause serious side effects. Since this study involves no medication or procedures that enter the body, the risk remains very low.

In summary, previous research and widespread use indicate that these home monitoring devices are safe for use.

Home monitoring for interstitial lung disease (ILD) is unique because it empowers patients to track their lung health from the comfort of their own homes. Unlike traditional treatments that often require frequent hospital visits for monitoring, this method uses devices like spirometers, pulse oximeters, and wireless scales to gather valuable health data remotely. Researchers are excited about this approach because it could lead to earlier detection of changes in lung health, prompt interventions, and ultimately improve patient outcomes. By utilizing technology to bring monitoring directly to patients, this trial aims to enhance convenience and potentially transform how ILD is managed.

This trial compares different home monitoring approaches for interstitial lung disease (ILD). Participants will be randomized into one of four arms. Studies have shown that monitoring ILD from home can be effective and valuable. Remote tools like spirometry (a test to check lung function) and pulse oximetry (which measures oxygen levels) track ILD progression. Research indicates that these tools are safe and acceptable to patients, offering a promising way to manage the disease at home. Evidence also suggests that they can improve access to care and potentially enhance the quality of life for those with ILD.¹²³⁴⁵